• Kristine Phillips, Ann Taylor, Philip J Mease, Lee S Simon, Philip G Conaghan, Ernest H Choy, Jasvinder A Singh, Vibeke Strand, Laure Gossec, Ulrike Kaiser, Marteen de Wit, Raymond Ostelo, Lara Maxwell, and Peter S Tugwell.
• From the Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA; Cardiff University, Cardiff, UK; Swedish Medical Center and University of Washington, Seattle, Washington, USA; SDG LLC, Cambridge, Massachusetts, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; University of Alabama at Birmingham, Birmingham, Alabama; Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA; University Hospital Carl Gustav Carus, Dresden, Germany; Universite Pierre et Marie Curie and APHP, Department of Rheumatology, Pitie-Salpetriere Hospital, Paris, France; EMGO Institute for Health and Care Research, Department of Health Sciences, VU University, and Department of Epidemiology and Biostatistics, VU University Medical Center, VU Medical Center, Amsterdam, The Netherlands. kphill@umich.edu.
• J Rheumatol. 2015 Oct 1; 42 (10): 1943-1946.

ObjectiveA variety of authorities in pain measurement and outcome methodology met prior to the Outcome Measures in Rheumatology (OMERACT) 12 meeting in May 2014 to develop partnerships for consensus on pain outcomes.MethodsFollowing overview presentations, discussion centered on pain-specific and global constructs in the domain of chronic pain. Practical issues for clinical trial implementation were also discussed. Breakout sessions were completed regarding additional details of domain constructs. A nominal group process involving all workshop participants confirmed that chronic pain outcome measures encompass a broad range of constructs and that existing scales may be inadequate for assessment in clinical trials.ResultsParticipants endorsed that both pain intensity and pain interference are important constructs to be measured in clinical trials of chronic pain as it pertains to rheumatologic diagnoses.ConclusionFurther work is needed on inclusion of the patient perspective in the development of pain domains as well as Cochrane Collaboration summary of findings tables.

4 keywords...

hide…